CAD & Atherosclerosis
Conference Coverage
IMPROVE-IT: Ezetimibe/simvastatin further reduces cardiovascular events
Key clinical point: Combined therapy with ezetimibe and simvastatin reduces cardiovascular events more than simvastatin alone in high-risk...
News
CABG beats PCI for revascularization of diabetics
Key clinical point: CABG is the preferred long-term revascularization technique for diabetics. Major finding: Diabetic patients with multivessel...
Conference Coverage
Stress more dangerous for women with heart disease than for men
Key clinical point: Younger women with stable coronary heart disease suffer greater stress-induced myocardial ischemia than men do. Major finding...
News
Nonobstructive CAD increases risk of MI and death
Key clinical point: Nonobstructive coronary artery disease is associated with a significant increase in the risk of myocardial infarction and...
News
Postcarotid stenting hemodynamic instability doesn’t increase stroke risk
Key clinical point: Prolonged hemodynamic instability after carotid artery stenting is associated with increased incidence of TIA, but not MI or...
News
Tocilizumab and tofacitinib increase lipids in RA patients
Key clinical point: The biologic tocilizumab and the JAK inhibitor increase lipid levels in RA patients.
News
FDA panel supports retaining Chantix boxed warning for now
Feature
FDA panel supports retaining Chantix boxed warning for now
The boxed warning about the risk of serious neuropsychiatric effects associated with the smoking cessation drug varenicline should remain on the...
News
Intensive glycemic control safely cut end-stage renal disease
Key clinical point: Intensive glycemic control in patients with type 2 diabetes safely led to a long-term reduction in end-stage kidney disease,...
News
‘Healthy immigrant effect’ persists even after a decade
Key clinical point: Diabetic immigrants to Ontario from low-income countries appear to have a lower risk of cardiovascular events and all-cause...
News
Long-term insulin use had no heart effects in ORIGINALE
Key clinical point: People at high risk for cardiovascular disease with dysglycemia or type 2 diabetes can be reassured about the long-term safety...